Atara Biotherapeutics announces 2025 annual meeting results; all proposals approved

Atara Biotherapeutics, Inc.

Elected directors: AnhCo Nguyen (2.71M for), Matthew Fust (2.58M for), Gregory Ciongoli (2.99M for).
Advisory vote on executive compensation approved 2.98M for vs 43K against.
Frequency of say-on-pay set to one year (3.00M votes for one year).
Ratified Deloitte & Touche as auditor for FY2025 with 4.39M for, 69K against, 79K abstain.

item 5.07

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.